Summary

The Global Respiratory Pathogen Testing Kits Market was valued at USD 2.45 billion in 2023 and is projected to grow at a CAGR of 5.5% from 2024 to 2032. Respiratory tract infections, ranging from self-limiting upper respiratory tract infections like the common cold to severe lower respiratory tract infections such as bronchitis, bronchiolitis, pneumonitis, and pneumonia, are among the most common diseases affecting humans. These infections pose a significant disease burden, especially lower respiratory tract infections (LRTIs), which are a major cause of hospitalization, morbidity, and mortality, particularly in infants and the elderly.

The Respiratory Pathogen Testing Kits Market is witnessing surge in demand driven by innovations in the diagnostic and biotech industries, which aim to address the massive incidence of respiratory infections. The launch of new testing kits using advanced technology by key players is positively impacting market growth. Furthermore, the development of the healthcare industry in emerging economies, due to significant investments by governments to improve healthcare infrastructure and the growth of the medical tourism industry, is expected to create substantial growth opportunities for the respiratory pathogen testing kits market. The rise of e-commerce as a preferred method of purchasing, increasing awareness towards pathogen testing, and promotional activities by manufacturers are also supporting market growth. However, challenges such as high installation costs of advanced electronic heat meters, technological obsolescence, and unfavorable regulatory scenarios may hinder market growth.
The key region studied in Global Respiratory Pathogen Testing Kits Market includes North America, Asia Pacific, Europe, Latin America and Middle East and Africa. North America is the leading region, driven by its advanced healthcare infrastructure, significant investments in research and development, and high demand for innovative diagnostic solutions. The region benefits from strong regulatory frameworks and widespread adoption of advanced medical technologies, which bolster market growth. In contrast, the Asia-Pacific region is the fastest-growing market, primarily due to rapid urbanization, increasing healthcare expenditure, and rising awareness about respiratory diseases. The expanding population and the growing prevalence of respiratory infections in countries like China and India contribute to the accelerated demand for testing kits. Additionally, the region's improving healthcare infrastructure and government initiatives aimed at enhancing diagnostic capabilities are fueling this rapid growth. The convergence of these factors positions the Asia-Pacific region as a dynamic and fast-evolving player in the global Respiratory Pathogen Testing Kits market.

Major market players included in this report are:
Abbott Laboratories
Altona Diagnostics
Becton Dickinson and Company
bioMérieux Inc.
Danaher Corporation (Cepheid)
F. Hoffmann-La Roche Ltd.
Mylab Discovery Solutions Pvt Ltd.
Siemens Healthineers AG
Sysmex Corporation
Thermo Fisher Scientific Inc.
Qiagen NV
BIOMERIEUX SA
Mylab Discovery Solutions Private Limited
Becton, Dickinson and Company
Siemens AG

The detailed segments and sub-segment of the market are explained below:
By Product Type
RT PCR Kits
Lateral Flow Test Kits
ELISA Kits
Others

By Application
Influenza Virus Infection
Respiratory Syncytial Virus Infection
Others

By End User
Hospitals
Diagnostic Centers
Others

By Region:
North America
U.S.
Canada

Europe
Germany
France
UK
Italy
Spain
Rest of Europe

Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific

Latin America
Brazil
Mexico
Rest of Latin America

Middle East and Africa
Saudi Arabia
South Africa
Rest of Middle East and Africa

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Chapter 1. Global Respiratory Pathogen Testing Kits Market Executive Summary
1.1. Global Respiratory Pathogen Testing Kits Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Application
1.3.3. By End User
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Respiratory Pathogen Testing Kits Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer’s Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates

Chapter 3. Global Respiratory Pathogen Testing Kits Market Dynamics
3.1. Market Drivers
3.1.1. Growth & Innovations in the Diagnostic and Biotech Industry
3.1.2. Rise in Healthcare Expenditure and Hospital Admissions
3.2. Market Challenges
3.2.1. High Installation Costs
3.2.2. Technological Obsolescence
3.3. Market Opportunities
3.3.1. Increasing Adoption of Smart Building Technologies
3.3.2. Growth in Emerging Markets

Chapter 4. Global Respiratory Pathogen Testing Kits Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Respiratory Pathogen Testing Kits Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Respiratory Pathogen Testing Kits Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. RT PCR Kits
5.2.2. Lateral Flow Test Kits
5.2.3. ELISA Kits
5.2.4. Others

Chapter 6. Global Respiratory Pathogen Testing Kits Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Respiratory Pathogen Testing Kits Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Influenza Virus Infection
6.2.2. Respiratory Syncytial Virus Infection
6.2.3. Others

Chapter 7. Global Respiratory Pathogen Testing Kits Market Size & Forecasts by End User 2022-2032
7.1. Segment Dashboard
7.2. Global Respiratory Pathogen Testing Kits Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals
7.2.2. Diagnostic Centers
7.2.3. Others

Chapter 8. Global Respiratory Pathogen Testing Kits Market Size & Forecasts by Region 2022-2032
8.1. North America Respiratory Pathogen Testing Kits Market
8.1.1. U.S. Respiratory Pathogen Testing Kits Market
8.1.2. Canada Respiratory Pathogen Testing Kits Market
8.1.3. Mexico Respiratory Pathogen Testing Kits Market
8.2. Europe Respiratory Pathogen Testing Kits Market
8.2.1. U.K. Respiratory Pathogen Testing Kits Market
8.2.2. Germany Respiratory Pathogen Testing Kits Market
8.2.3. France Respiratory Pathogen Testing Kits Market
8.2.4. Spain Respiratory Pathogen Testing Kits Market
8.2.5. Italy Respiratory Pathogen Testing Kits Market
8.2.6. Rest of Europe Respiratory Pathogen Testing Kits Market
8.3. Asia-Pacific Respiratory Pathogen Testing Kits Market
8.3.1. China Respiratory Pathogen Testing Kits Market
8.3.2. Japan Respiratory Pathogen Testing Kits Market
8.3.3. India Respiratory Pathogen Testing Kits Market
8.3.4. Australia Respiratory Pathogen Testing Kits Market
8.3.5. South Korea Respiratory Pathogen Testing Kits Market
8.3.6. Rest of Asia Pacific Respiratory Pathogen Testing Kits Market
8.4. Latin America Respiratory Pathogen Testing Kits Market
8.4.1. Brazil Respiratory Pathogen Testing Kits Market
8.4.2. Mexico Respiratory Pathogen Testing Kits Market
8.4.3. Rest of Latin America Respiratory Pathogen Testing Kits Market
8.5. Middle East & Africa Respiratory Pathogen Testing Kits Market
8.5.1. Saudi Arabia Respiratory Pathogen Testing Kits Market
8.5.2. South Africa Respiratory Pathogen Testing Kits Market
8.5.3. Rest of Middle East & Africa Respiratory Pathogen Testing Kits Market

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Abbott Laboratories
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. Altona Diagnostics
9.3.3. Becton Dickinson and Company
9.3.4. bioMérieux Inc.
9.3.5. Danaher Corporation (Cepheid)
9.3.6. F. Hoffmann-La Roche Ltd.
9.3.7. Mylab Discovery Solutions Pvt Ltd.
9.3.8. Siemens Healthineers AG
9.3.9. Thermo Fisher Scientific Inc.
9.3.10. Sysmex Corporation
9.3.11. Qiagen NV
9.3.12. BIOMERIEUX SA
9.3.13. Mylab Discovery Solutions Private Limited
9.3.14. Becton, Dickinson and Company
9.3.15 Siemens AG

Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes